In a study revealing immune cell infiltration and immunotherapy in low-grade gliomas, high immune infiltration scores were significantly associated with increased levels of CD4 naïve T cell infiltration, and high CD4 naïve T cell expression suggested a good prognosis for patients (30). The gene discussed is CD4; the disease is central nervous system cancer.